⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9434282 | 0.72 | — | — | |
| SCHEMBL1989509 | 0.72 | — | — | |
| SCHEMBL1441894 | 0.72 | — | — | |
| SCHEMBL21830193 | 0.70 | — | — | |
| SCHEMBL1775067 | 0.70 | — | — | |
| SCHEMBL29262189 | 0.70 | — | — | |
| SCHEMBL6341539 | 0.70 | — | — | |
| SCHEMBL1459722 | 0.70 | — | — | |
| Iodide SCHEMBL29198705 | 0.68 | — | — | |
| Bromide SCHEMBL29198604 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228480-A1 | PROCESSES FOR PREPARING PYRROLOPYRIDINE-ANILINE COMPOUNDS | CURIA GLOBAL, INC. | 2024-07-11 | — | — | US | disclosed |
| EP-4281069-A1 | PROCESSES FOR PREPARING PYRROLOPYRIDINE-ANILINE COMPOUNDS | NFlection Therapeutics, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| CN-117136056-A | Process for preparing pyrrolopyridine-anilines | 恩福莱克逊治疗有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-110845439-B | Method for synthesizing 2-substituted benzothiazole by one-pot method | 南京工业大学 | 2023-04-11 | — | — | CN | disclosed |
| WO-2013036232-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES | DECIPHERA PHARMACEUTICALS, LLC (US) | 2013-03-14 | — | — | WO | disclosed |
| EP-1857440-A1 | Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same | Amorepacific Corporation (KR) | 2007-11-21 | — | — | EP | disclosed |
| WO-2007120012-A1 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2007-10-25 | — | — | WO | disclosed |